GALE logo
GALE
Galenica

Expanding Diagnostics And Digital Health Will Transform Healthcare Markets

Published
16 Mar 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
CHF 83.80
0.5% overvalued intrinsic discount
14 Aug
CHF 84.20
Loading
1Y
16.5%
7D
-1.5%

Author's Valuation

CHF 83.8

0.5% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates7

Shared on01 May 25
Fair value Increased 5.54%

Read more

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Increased 0.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Decreased 6.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more